The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

February 1, 2023

Study Completion Date

August 31, 2023

Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST

Transbronchial forceps biopsy

All patients with peripheral lung lesion suspected of lung cancer detected on the chest computed tomography (CT) and mini probe endobronchial ultrasound (RP-EBUS) scans were enrolled. Transbronchial forceps biopsy (TBFB) was performed for all these patients.

DIAGNOSTIC_TEST

Transbronchial forceps biopsy+Transbronchial cryobiopsy

All patients with peripheral lung lesion suspected of lung cancer detected on the chest computed tomography (CT) and RP-EBUS scans were enrolled. TBFB was performed for all these patients. In addition, all of these patients, with no contraindications, underwent transbronchial cryobiopsy (TBCB)

Trial Locations (1)

LT 44307

Lithuanian University of Health Sciences, Kaunas

All Listed Sponsors
lead

Lithuanian University of Health Sciences

OTHER

NCT05164445 - The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer | Biotech Hunter | Biotech Hunter